Nana-Kwadwo Biritwum1,2, Dziedzom K de Souza3, Odame Asiedu4, Benjamin Marfo4, Uche Veronica Amazigo5,6, John Owusu Gyapong7. 1. Neglected Tropical Diseases Programme, Ghana Health Service, Accra, Ghana. nkadbiritwum@gmail.com. 2. Bill & Melinda Gates Foundation, Seattle, USA. nkadbiritwum@gmail.com. 3. Department of Parasitology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon-Accra, Ghana. 4. Neglected Tropical Diseases Programme, Ghana Health Service, Accra, Ghana. 5. Pan-African Community Initiative on Education and Health (PACIEH), Enugu, Nigeria. 6. University of Nigeria, Nsukka, Enugu, Nigeria. 7. University of Health and Allied Sciences, Ho, Ghana.
Abstract
BACKGROUND: The control of onchocerciasis in Ghana started in 1974 under the auspices of the Onchocerciasis Control Programme (OCP). Between 1974 and 2002, a combination of approaches including vector control, mobile community ivermectin treatment, and community-directed treatment with ivermectin (CDTI) were employed. From 1997, CDTI became the main control strategy employed by the Ghana OCP (GOCP). This review was undertaken to assess the impact of the control interventions on onchocerciasis in Ghana between 1974 and 2016, since which time the focus has changed from control to elimination. METHODS: In this paper, we review programme data from 1974 to 2016 to assess the impact of control activities on prevalence indicators of onchocerciasis. This review includes an evaluation of CDTI implementation, microfilaria (Mf) prevalence assessments and rapid epidemiological mapping of onchocerciasis results. RESULTS: This review indicates that the control of onchocerciasis in Ghana has been very successful, with a significant decrease in the prevalence of infection from 69.13% [95% confidence interval) CI 60.24-78.01] in 1975 to 0.72% (95% CI 0.19-1.26) in 2015. Similarly, the mean community Mf load decreased from 14.48 MF/skin snip in 1975 to 0.07 MF/skin snip (95% CI 0.00-0.19) in 2015. Between 1997 and 2016, the therapeutic coverage increased from 58.50 to 83.80%, with nearly 100 million ivermectin tablets distributed. CONCLUSIONS: Despite the significant reduction in the prevalence of onchocerciasis in Ghana, there are still communities with MF prevalence above 1%. As the focus of the GOCP has changed from the control of onchocerciasis to its elimination, both guidance and financial support are required to ensure that the latter goal is met.
BACKGROUND: The control of onchocerciasis in Ghana started in 1974 under the auspices of the Onchocerciasis Control Programme (OCP). Between 1974 and 2002, a combination of approaches including vector control, mobile community ivermectin treatment, and community-directed treatment with ivermectin (CDTI) were employed. From 1997, CDTI became the main control strategy employed by the Ghana OCP (GOCP). This review was undertaken to assess the impact of the control interventions on onchocerciasis in Ghana between 1974 and 2016, since which time the focus has changed from control to elimination. METHODS: In this paper, we review programme data from 1974 to 2016 to assess the impact of control activities on prevalence indicators of onchocerciasis. This review includes an evaluation of CDTI implementation, microfilaria (Mf) prevalence assessments and rapid epidemiological mapping of onchocerciasis results. RESULTS: This review indicates that the control of onchocerciasis in Ghana has been very successful, with a significant decrease in the prevalence of infection from 69.13% [95% confidence interval) CI 60.24-78.01] in 1975 to 0.72% (95% CI 0.19-1.26) in 2015. Similarly, the mean community Mf load decreased from 14.48 MF/skin snip in 1975 to 0.07 MF/skin snip (95% CI 0.00-0.19) in 2015. Between 1997 and 2016, the therapeutic coverage increased from 58.50 to 83.80%, with nearly 100 million ivermectin tablets distributed. CONCLUSIONS: Despite the significant reduction in the prevalence of onchocerciasis in Ghana, there are still communities with MF prevalence above 1%. As the focus of the GOCP has changed from the control of onchocerciasis to its elimination, both guidance and financial support are required to ensure that the latter goal is met.
Entities:
Keywords:
Community-directed ivermectin treatment; Ghana; Ivermectin; Onchocerciasis control
Authors: Michael Ekuoba Gyasi; Agana Nsiire; Daniel Yayemain; Oscar Afari Debrah; Delali Asamani; John Gyapong; Winfried M K Amoaku Journal: Ophthalmic Epidemiol Date: 2010-12 Impact factor: 1.648
Authors: Young Eun Kim; Jan H F Remme; Peter Steinmann; Wilma A Stolk; Jean-Baptiste Roungou; Fabrizio Tediosi Journal: PLoS Negl Trop Dis Date: 2015-04-10
Authors: Poppy H L Lamberton; Robert A Cheke; Martin Walker; Peter Winskill; J Lee Crainey; Daniel A Boakye; Mike Y Osei-Atweneboana; Iñaki Tirados; Michael D Wilson; Anthony Tetteh-Kumah; Sampson Otoo; Rory J Post; María-Gloria Basañez Journal: Parasit Vectors Date: 2016-08-05 Impact factor: 3.876
Authors: Nana-Kwadwo Biritwum; Dziedzom K de Souza; Benjamin Marfo; Samuel Odoom; Bright Alomatu; Odame Asiedu; Abednego Yeboah; Tei E Hervie; Ernest O Mensah; Paul Yikpotey; Joseph B Koroma; David Molyneux; Moses J Bockarie; John O Gyapong Journal: PLoS Negl Trop Dis Date: 2017-03-23
Authors: Mark J Taylor; Kwablah Awadzi; María-Gloria Basáñez; Nana Biritwum; Daniel Boakye; Boakye Boatin; Moses Bockarie; Thomas S Churcher; Alex Debrah; Geoffrey Edwards; Achim Hoerauf; Sabine Mand; Graham Matthews; Mike Osei-Atweneboana; Roger K Prichard; Samuel Wanji; Ohene Adjei Journal: Parasit Vectors Date: 2009-01-21 Impact factor: 3.876
Authors: Kwadwo K Frempong; Martin Walker; Robert A Cheke; Edward Jenner Tetevi; Ernest Tawiah Gyan; Ebenezer O Owusu; Michael D Wilson; Daniel A Boakye; Mark J Taylor; Nana-Kwadwo Biritwum; Mike Osei-Atweneboana; María-Gloria Basáñez Journal: Clin Infect Dis Date: 2016-03-21 Impact factor: 9.079
Authors: Laura Willen; Philip Milton; Jonathan I D Hamley; Martin Walker; Mike Y Osei-Atweneboana; Petr Volf; Maria-Gloria Basáñez; Orin Courtenay Journal: PLoS Negl Trop Dis Date: 2022-01-12